Midterm impact of sleeve gastrectomy, calibrated with a 50-Fr bougie, on weight loss, glucose homeostasis, lipid profiles, and comorbidities in morbidly obese patients

American Surgeon

Volumn 78, Issue 9, 2012, Pages 969-974

  Ruiz Tovar, Jaime ^a   Oller, Inmaculada ^a   Tomas, Andres ^a   Llavero, Carolina ^b   Arroyo, Antonio ^a   Calero, Alicia ^a   Martinez Blasco, Amparo ^a   Calpena, Rafael ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b Hospital del Sureste   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BOUGIE; CALIBRATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LAPAROSCOPIC SURGERY; LIPID ANALYSIS; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; SLEEVE GASTRECTOMY; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BODY MASS INDEX; CALIBRATION; COMORBIDITY; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; HOMEOSTASIS; HUMANS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LIPIDS; MALE; MIDDLE AGED; OBESITY, MORBID; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84866004739     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004;89:2583-9. (Pubitemid 38766335)
2. Sullivan PW, Ghushchyan VH, Ben-Joseph R. The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. Qual Life Res 2008;17:1063-71.
3. Nguyen NT, Magno CP, Lane KT, et al. Association of hypertension, diabetes, dyslipidemia and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey 1999 to 2004. J Am Coll Surg 2008;207:928-34.
4. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724-37. (Pubitemid 39346675)
5. Cottam D, Qureshi FG, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc 2006;20:859-63. (Pubitemid 43825185)
6. Melissas J, Daskalakis M, Koukouraki S, et al. Sleeve gastrectomy - a 'food limiting' operation. Obes Surg 2008;18:1251-6.
7. Zhang F, Strain GW, Lei W, et al. Changes in lipid profiles in morbidly obese patients after laparoscopic sleeve gastrectomy. Obes Surg 2011;21:305-9.
8. Langer FB, Reza Hoda MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005;15:1024-9. (Pubitemid 41116888)
9. Peterli R, Wolnerhanssen B, Peters T, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 2009;250:234-41.
10. Vidal J, Ibarzabal A, Romero F, et al. Type 2 diabetes mellitus and the metabolic síndrome following sleeve gastrectomy in severely obese patients. Obes Surg 2008;18:1077-82.
11. Nosso G, Angrisani L, Saldalamacchia G, et al. Impact of sleeve gastrectomy on weight loss, glucose homeostasis and comorbidities in severely obese type 2 diabetic subjects. J Obes 2011;2011:340867.
12. Gill RS, Sharma AM, Al-Adra DP, et al. The impact of bariatric surgery in patients with type-2 diabetes mellitus. Curr Diabetes Rev 2011;7:185-9.
13. Marantos G, Daskalakis M, Karkavitsas N, et al. Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with restrictive bariatric surgery. World J Surg 2011;35:2022-30.
14. Parikh M, Gagner M, Heacock L, et al. Laparoscopic sleeve gastrectomy: does bougie size affect mean %EWL? Short-term outcomes. Surg Obes Relat Dis 2008;4:528-33. (Pubitemid 352006164)
15. Atkins ER, Preen DB, Jarman C, et al. Improved obesity reduction and comorbidity resolution in patients treated with 40-French Bougie versus 50-French Bougie four years after laparoscopic sleeve gastrectomy. Analysis of 294 patients. Obes Surg 2012;22:97-104.
16. Ferrer-Marquez M, Belda-Lozano R, Ferrer-Ayza M. Technical controversies in laparoscopic sleeve gastrectomy. Obes Surg 2012;22:182-7.
17. Skrekas G, Lapatsanis D, Stafyla V, Papalambros A. One year after laparoscopic 'tight' sleeve gastrectomy: technique and outcome. Obes Surg 2008;18:810-3.
18. Rizzello M, Abbatini F, Casella G, et al. Early postoperative insulin-resistance changes alter sleeve gastrectomy. Obes Surg 2010;20:50-5.
19. Abbatini F, Rizzello M, Casella G, et al. Long-term effects of sleeve gastrectomy, gastric bypass and adjustable gastric banding on type 2 diabetes. Surg Endosc 2010;24:1005-10.
20. Shah PS, Todkar JS, Shah SS. Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis 2010;6:138-41.
21. DePaula AL, Macedo AL, Mota BR, Schraibman V. Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. Surg Endosc 2009;23:1313-20.
22. Woelnerhanssen B, Peterli R, Steinert RE, et al. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy - a prospective randomized trial. Surg Obes Relat Dis 2011;7:561-8.
23. Chambers AP, Stefater MA, Wilson-Perez HE, et al. Similar effects of Roux-en-Y gastric bypass and vertical sleeve gastrectomy on glucose regulation in rats. Physiol Behav 2011;105:120-3.
24. Li F, Zhang G, Liang J, et al. Sleeve gastrectomy provides a better control of diabetes by decreasing ghrelin in the diabetic Goto-Kakizaki rats. J Gastrointest Surg 2009;13:2302-8.
25. Hauser H, Dyer JH, Nandy A, et al. Identification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry 1998;37:17843-50. (Pubitemid 29023939)
26. Vierhapper H, Heinze G, Nowotny P, Bieglmayer C. Serum concentrations of dehydroepiandrosterone sulphate and leptin in obese patients with normal serum cholesterol. Metabolism 2003;52:379-81. (Pubitemid 36401685)
27. Vierhapper H, Nardi A, Grosser P. Prevalence of paradoxically normal serum cholesterol in morbidly obese women. Metabolism 2000;49:607-10. (Pubitemid 30305258)
28. Gaziano JM, Hennekens CH, O'Donnell CJ, et al. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 1997;96:2520-5. (Pubitemid 27451340)
29. Vila M, Ruiz O, Belmonte M, et al. Changes in lipid profile and insulin resistance in obese patients after Scopinaro biliopancreatic diversion. Obes Surg 2009;19:299-306.